Immunological Studies in Ugandan Patients with Hepatocellular Carcinoma
- 6 January 1973
- Vol. 1 (5844), 16-19
- https://doi.org/10.1136/bmj.1.5844.16
Abstract
Immunological studies were performed on Ugandan patients with hepatocellular carcinoma to test the hypothesis that the high rate of persistence of hepatitis-associated antigen in these patients is the result of defects in host immune response. The responses to 1-chloro-2,4-dinitrobenzene sensitization and to a battery of recall skin test antigens were normal, as was the humoral antibody response to tularaemia antigen. Neither hypogammaglobulinaemia nor specific immunoglobulin deficiencies were found. Thus it appears unlikely that generalized defects in host immune responses can account for the high incidence of persistent hepatitis B virus infection found in Ugandan patients with hepatocellular carcinoma.Keywords
This publication has 22 references indexed in Scilit:
- H.A.A. IN PRIMARY LIVER-CELL CARCINOMAThe Lancet, 1971
- HEPATITIS-ASSOCIATED ANTIGEN AND HEPATOCELLULAR CARCINOMAThe Lancet, 1971
- S.H. ANTIGEN AND CHRONIC LIVER DISEASEThe Lancet, 1970
- HEPATITIS-ASSOCIATED ANTIGEN IN UGANDAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1970
- HEPATITIS-ASSOCIATED ANTIGEN IN CHRONIC LIVER DISEASEThe Lancet, 1970
- CHRONIC LIVER DISEASE AND PRIMARY LIVER-CELL CANCER WITH HEPATITIS-ASSOCIATED (AUSTRALIA) ANTIGEN IN SERUMThe Lancet, 1970
- VIRAL HEPATITIS, POSTNECROTIC CIRRHOSIS, AND HEPATOCELLULAR CARCINOMAThe Lancet, 1969
- Human Leukocyte Antigenic Specificity HL-A3: Frequency of OccurrenceScience, 1969
- Observations on Australia Antigen in JapaneseVox Sanguinis, 1968
- IMPAIRED DELAYED HYPERSENSITIVITY IN PATIENTS WITH LEPROMATOUS LEPROSYThe Lancet, 1966